A2 Milk Company Ltd (ASX: A2M) shares ended up having a stellar finish to the year in FY24.
In total, shares in the specialty milk company rose 38%, starting the year at $4.89 and closing the period at $6.77 apiece.
Most of this was achieved in the second half, as seen in the chart below.
Leading into the New Year, the stock was trading at $4.26 before exploding to 52-week highs of $7.33 on 28 May.
With A2 Milk shares up more than 2.5% in the past week, the question is, will FY25 be a similar affair?
Drivers of A2 Milk shares
There was a buying thrust in A2 Milk shares after the company’s H1 FY24 earnings report in February. In it, A2 Milk reported a 3.7% increase in revenue to NZ$812.1 million.
This growth was underscored by A2 Milk’s continued expansion in its China and Other Asia markets, with sales up 16.5% in those regions.
Sales of infant milk formula (IMF) in China were up 10.4% alone. Meanwhile, its Australia and New Zealand business saw a 24.1% decrease compared to H1 FY23.
Net profit after tax (NPAT) was also up 15.6% year over year and management forecasts “low to mid-single-digit” revenue growth for FY24, according to my colleague James.
In May it voted in favour of a $130 million loan to Synlait Milk Ltd (ASX: SM1), in which it holds a nearly 20% stake.
According to my colleague Bernd, the loan, provided by Bright Dairy, aims to support Synlait’s recapitalisation plan. Bright owns around 40% of Synlait Milk.
What are brokers saying for FY25?
Brokers have a mixed yet generally optimistic outlook on A2 Milk shares.
In an April note, Bell Potter rated the company a hold with a $5.70 price target on its stock. It said that while the company’s transition has been executed well, its shares could be fully valued.
Despite its recent Growth in China, Bell Potter is weary, saying imports are “at historically low levels and has been since Jun 2023”.
On the other hand, Ord Minnett rated A2 Milk a buy in a February note. It has a $7.40 price target for the share, implying a 7.5% potential upside from the current price.
Analysts at Citi are also bullish on the stock and reaffirmed the firm’s buy rating in June. It values the company at $7.85 per share.
Meanwhile, consensus rate A2 Milk shares a hold according to CommSec. The split is three buys, five holds and one sell.
Foolish takeout
As we walk through FY25, A2 Milk shares continue to push higher. They are up more than 1.5% since trading began in the new financial year, and up 36% in the past twelve months. As always, remember to conduct your own due diligence.
The post Here’s why A2 Milk shares soared in FY24. Will it happen again? appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…
See The 5 Stocks
*Returns as of 10 July 2024
More reading
- A2 Milk shares lift amid backing for $130 million Synlait loan
- Why A2 Milk, Actinogen Medical, Karoon Energy, and Race Oncology shares are rising
- Here are the top 10 ASX 200 shares today
- Guess which A2 Milk rival’s shares just rocketed 21% on US news!
Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
Leave a Reply